Pain Modulation in Chronic Musculoskeletal Disorders: Botulinum Toxin, a Descriptive Analysis
Botulinum neurotoxin (BoNT), a product of Clostridium botulinum, reversibly inhibits the presynaptic release of the neurotransmitter acetylcholine at the neuromuscular junction. In addition, BoNT blocks the transmission of other substances involved in pain perception and, together with a soft-tissue...
Main Authors: | Daniela Poenaru, Miruna Ioana Sandulescu, Delia Cinteza |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/7/1888 |
Similar Items
-
Botulinum Toxin for the Treatment of Neuropathic Pain
by: JungHyun Park, et al.
Published: (2017-08-01) -
Dataset of botulinum toxin A influence on interleukins under neuropathy
by: Magdalena Zychowska, et al.
Published: (2016-12-01) -
Botulinum Toxin as a Pain Killer: Players and Actions in Antinociception
by: Dong-Wan Kim, et al.
Published: (2015-06-01) -
Botulinum Toxin Treatment for Cancer-Related Disorders: A Systematic Review
by: Delaram Safarpour, et al.
Published: (2023-12-01) -
Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation
by: Domenico Intiso, et al.
Published: (2015-06-01)